These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 10529161)
1. Treatment of rheumatoid arthritis with the dopamine agonist quinagolide. Eijsbouts A; van den Hoogen F; Laan RF; Hermus RM; Sweep FC; van de Putte L J Rheumatol; 1999 Oct; 26(10):2284-5. PubMed ID: 10529161 [No Abstract] [Full Text] [Related]
2. A case of mania after long-term use of quinagolide. Vinkers DJ; van der Wee NJ Gen Hosp Psychiatry; 2007; 29(5):464. PubMed ID: 17888817 [No Abstract] [Full Text] [Related]
3. [Treatment of macroprolactinomas with quinagolide (Norprolac)]. Tabarin A; Catargi B Ann Endocrinol (Paris); 1997; 58(2):87-94. PubMed ID: 9239226 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of quinagolide in the treatment of a patient with hypophyseal resistance to thyroid hormones]. De Luis DA; Lahera M; Botella JI; Valero MA; Varela C An Med Interna; 2001 May; 18(5):259-61. PubMed ID: 11496561 [TBL] [Abstract][Full Text] [Related]
5. Hypogonadism secondary to hyperprolactinaemia: successful treatment but adverse consequences. Narayanan RP; Bujawansa S; Qureshi Z; Rimmer M; Heald A Exp Clin Endocrinol Diabetes; 2012 May; 120(5):311-3. PubMed ID: 22441722 [TBL] [Abstract][Full Text] [Related]
7. Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide. Hrycek A; Kokocińska D; Kośmider J; Konieczny B Lupus; 2003; 12(2):149-52. PubMed ID: 12630763 [No Abstract] [Full Text] [Related]
8. Pilot study on the treatment of cyclical mastodynia with Quinagolide. Ioannidou-Mouzaka L; Niagassas M; Galanos A; Kalovidouris A Eur J Gynaecol Oncol; 1999; 20(2):117-21. PubMed ID: 10376428 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists. Kars M; Pereira AM; Smit JW; Romijn JA Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180 [TBL] [Abstract][Full Text] [Related]
14. Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists. Kontogeorgos G; Horvath E; Kovacs K; Coire C; Lloyd RV; Scheithauer BW; Smyth HS Acta Neuropathol; 2006 Jan; 111(1):46-52. PubMed ID: 16328513 [TBL] [Abstract][Full Text] [Related]
15. Dopamine agonist withdrawal syndrome (DAWS) in a patient with a microprolactinoma. Demartini B; Ricciardi L; Ward A; Edwards MJ J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):471. PubMed ID: 24078717 [No Abstract] [Full Text] [Related]
16. CV 205-502: a more effective dopamine agonist in the treatment of acromegaly? Jaquet P Eur J Endocrinol; 1995 May; 132(5):557-8. PubMed ID: 7749495 [No Abstract] [Full Text] [Related]